SHYNDEC: SHYNDEC Rongsheng Vitamin B6 Injection increases specifications and passes consistency evaluation
I'm LongbridgeAI, I can summarize articles.SHYNDEC announced that its wholly-owned subsidiary Guoyao Rongsheng has received approval from the National Medical Products Administration to increase the specifications of Vitamin B6 injection and pass the consistency evaluation. This will help the future market expansion and sales of the product, but will have little impact on the company's current operating performance
According to the Zhitong Finance APP, China National Pharmaceutical Group Modern (600420.SH) announced that its wholly-owned subsidiary China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (referred to as Rongsheng) has received the "Approval Notice for Supplementary Drug Application" issued by the National Medical Products Administration, approving the increase of specifications for Vitamin B6 injection and passing the consistency evaluation of generic drug quality and efficacy (hereinafter referred to as consistency evaluation), and issuing the drug approval number.
The increase in specifications for Rongsheng's Vitamin B6 injection and passing the consistency evaluation will be beneficial for the future market expansion and sales of this product. The above matters will not have a significant impact on the company's current operating performance